Page last updated: 2024-11-09

beta-styrylacrylic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

beta-styrylacrylic acid: RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID1549512
CHEMBL ID1095566
CHEBI ID108600
MeSH IDM0053932

Synonyms (68)

Synonym
BRD-K12345912-001-02-3
(2e,4e)-5-phenyl-penta-2,4-dienoic acid
beta-styrylacrylic acid
nsc 63972
2,4-pentadienoic acid, 5-phenyl-
einecs 216-298-2
2,4-pentadienoic acid, 5-phenyl- (van)
nsc 109408
nsc 1778
nsc-1778
nsc1778
2,4-pentadienoic acid, 5-phenyl-,
nsc-50789
28010-12-0
nsc50789
SDCCGMLS-0066886.P001
BSPBIO_002523
SPECTRUM5_000481
(2e,4e)-5-phenylpenta-2,4-dienoic acid
5-phenyl-2,4-pentadienoic acid
1552-94-9
NCGC00095798-01
SPECTRUM203008
NCGC00095798-02
CHEBI:108600
AKOS000304438
5-phenylpenta-2,4-dienoic acid
(e,e)-cinnamylideneacetic acid
CHEMBL1095566
penta-2,4-dienoic acid, 5-phenyl-, (e,e)-
nsc 50789
S3978
CCG-40050
2,4-pentadienoicacid, 5-phenyl-, (2e,4e)-
cinnamylidene acetic acid
cinnamylideneacetic acid
4-phenyl-1,3-butadiene-1-carboxylic acid
5-phenylpenta-2,4-dienoicacid
juarezic acid
5-phenylpenta-2,4-diecoic acid
(2e,4e)-5-phenyl-2,4-pentadienoic acid
185152-35-6
mfcd00014018
J-515930
J-507259
sr-05000002408
SR-05000002408-1
5-phenyl-penta-2,4-dienoic acid
J-009185
CS-0030694
HY-N7129
5-phenylpenta-(2e,4e)-dienoic acid
5-phenyl-penta-2e,4e-dienoic acid
cinnamalacetic acid
AS-19080
P2422
BRD-K12345912-001-03-1
AMY40722
STL570453
A883658
5-phenylpenta-2,4-dienoic acid; cinnamylideneacetic acid; cinnamalacetic acid;5-phenyl-2,4-pentadienoic acid
1047682-56-3
(4e)-5-phenylpenta-2,4-dienoic acid
(2e)-5-phenylpenta-2,4-dienoic acid
F10302
EN300-1861098
EN300-1709710
2,4-pentadienoicacid,5-phenyl-,(2e,4e)-
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID477928Cytotoxicity against human PANC1 cells in nutrient-deprived condition assessed as preferential cell death after 24 hrs by trypan blue dye exclusion method2010Journal of natural products, Apr-23, Volume: 73, Issue:4
Study on the constituents of Mexican propolis and their cytotoxic activity against PANC-1 human pancreatic cancer cells.
AID592088Antihemorrhagic activity in ddY mouse assessed as inhibition of Protobothrops flavoviridis venom-induced hemorrhage incubated with compound for 10 mins measured after 24 hrs2011Bioorganic & medicinal chemistry, Apr-01, Volume: 19, Issue:7
Contribution of cinnamic acid analogues in rosmarinic acid to inhibition of snake venom induced hemorrhage.
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (4)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 13.13

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index13.13 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.92 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (13.13)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]